Trials / Completed
CompletedNCT01296542
A Comparison of Prophylactic Antibacterial Efficacy of Besivance vs. VIGAMOX Prior to Cataract Surgery
A Comparison of Prophylactic Antibacterial Efficacy of Besivance Versus VIGAMOX Administered for Three Days and One Hour Prior to Phacoemulsification
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Bucci Laser Vision Institute · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
To compare antibacterial efficacy of Besivance versus VIGAMOX for decreasing bacteria of the conjunctiva and lid margins in cataract patients prior to surgery after both 1 hour and 3 days of treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Moxifloxacin Ophthalmic | |
| DRUG | Besifloxacin Ophthalmic |
Timeline
- Start date
- 2011-05-01
- Primary completion
- 2013-01-01
- Completion
- 2013-01-01
- First posted
- 2011-02-15
- Last updated
- 2020-12-08
- Results posted
- 2020-12-08
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01296542. Inclusion in this directory is not an endorsement.